Search
for
Sort by
Research 181–210 of 1000+
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Pre-receptor regulation of the androgen receptor
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Omega-6 highly unsaturated fatty acids in Leydig cells facilitate male sex hormone production
- Сечова кислота в житті чоловіка
- Provenge is Talk of GU Malignancies Congress
- Erosive Pustular Dermatosis of the Scalp: A Clinicopathologic Study of Fifty Cases
- Frontal Fibrosing Alopecia in Men: A Review of the Literature
- Guidelines on the use of finasteride in androgenetic alopecia
- Finasteride en el año 2006
- Mitoxantrone
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
- Discontinuation of Alpha-Blockade after Initial Treatment with Finasteride and Doxazosin for Bladder Outlet Obstruction
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Regulation of masculinization: androgen signalling for external genitalia development
- Anti-androgenic activities of Ganoderma lucidum
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Reply
- Reply by the authors
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Adherence with protocol medication use and mortality from unrelated causes in a prevention trial
- Chemopr�vention des Prostatakarzinoms
- Biomarker-based methods for determining noncompliance in a prevention trial
- Finasteride Doesn't Shorten Survival in Long-term Study